AgomAb Therapeutics NV (AGMB)
10.51
-0.05
(-0.47%)
USD |
NASDAQ |
May 19, 16:00
11.40
+0.89
(+8.47%)
After-Hours: 07:37
AgomAb Therapeutics Shareholders Equity (Quarterly) : 153.74M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| UCB SA | -- |
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Total Liabilities (Quarterly) | 26.78M |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.488 |